La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease (blood) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease < Parkinson Disease (blood) < Parkinson Disease (cerebrospinal fluid)  Facettes :

List of bibliographic references indexed by Parkinson Disease (blood)

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000153 (2016) Qing He [République populaire de Chine] ; James B. Koprich [Canada] ; Ying Wang [République populaire de Chine] ; Wen-Bo Yu [République populaire de Chine] ; Bao-Guo Xiao [République populaire de Chine] ; Jonathan M. Brotchie [Canada] ; Jian Wang [République populaire de Chine]Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
000488 (2015) Janelle Drouin-Ouellet ; Isabelle St-Amour ; Martine Saint-Pierre ; Jérôme Lamontagne-Proulx ; Jasna Kriz ; Roger A. Barker ; Francesca CicchettiToll-Like Receptor Expression in the Blood and Brain of Patients and a Mouse Model of Parkinson’s Disease
000649 (2015) Lilah Toker ; Paul PavlidisMetaanalysis of flawed expression profiling data leading to erroneous Parkinson's biomarker identification
000712 (2015) Arash Nazeri [Canada] ; Tina Roostaei [Canada] ; Shokufeh Sadaghiani [Canada] ; M Mallar Chakravarty [Canada] ; Shirley Eberly [États-Unis] ; Anthony E. Lang [Canada] ; Aristotle N. Voineskos [Canada]Genome-wide variant by serum urate interaction in Parkinson's disease.
000993 (2014) C H Carriere [Canada] ; N H Kang [Canada] ; L P Niles [Canada]Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
000A47 (2014) Jeffrey Graham [Canada] ; Douglas Hobson [Canada] ; Arjuna Ponnampalam [Canada]High affinity hemoglobin and Parkinson's disease.
000D87 (2013) R. Abdalian [Canada] ; O. Saqui ; G. Fernandes ; J P AllardEffects of manganese from a commercial multi-trace element supplement in a population sample of Canadian patients on long-term parenteral nutrition.
000E11 (2013) Lilach Soreq [Israël] ; Hagai Bergman [Israël] ; Zvi Israel [Israël] ; Hermona Soreq [Israël]Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson’s patients leukocytes
001106 (2012) Lane K. Bekar [États-Unis] ; Helen S. Wei [États-Unis] ; Maiken Nedergaard [États-Unis]The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand
001191 (2012) Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. BrotchieL-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
001C04 (2010) Cory Toth [Canada] ; Kim Breithaupt [Canada] ; Shaohua Ge [Canada] ; Yanjun Duan [Canada] ; Joan M. Terris [Canada] ; Anita Thiessen [Canada] ; Samuel Wiebe [Canada] ; Douglas W. Zochodne [Canada] ; Oksana Suchowersky [Canada]Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease
001F94 (2009) Richard M. Camicioli [Canada] ; Thomas P. Bouchard [Canada] ; Martin J. Somerville [Canada]Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients
002703 (2006) R B Postuma [Canada] ; A J Espay ; C. Zadikoff ; O. Suchowersky ; W R W. Martin ; A-L Lafontaine ; R. Ranawaya ; R. Camicioli ; A E LangVitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.
002883 (2006) Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon StoesslAge-related differences in levodopa dynamics in Parkinson's: implications for motor complications
003104 (2002) J. M. Woulfe [Canada] ; R. Duke [Canada] ; J. M. Middeldorp [Pays-Bas] ; S. Stevens [Pays-Bas] ; M. Vervoort [Pays-Bas] ; M. Hashimoto [États-Unis] ; E. Masliah [États-Unis] ; P. Chan ; D. A. Di Monte [États-Unis] ; J. W. Langston [États-Unis] ; G. Petzinger [États-Unis] ; H. Hoogendoorn [Canada] ; D. G. Munoz [Canada, Espagne]Absence of elevated anti-α-synuclein and anti-EBV latent membrane protein antibodies in PD
004312 (1993) P. Cumming [Canada] ; G C Léger ; H. Kuwabara ; A. GjeddePharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
004551 (1992) Jawahar Kalra [Canada] ; Ali H. Rajput [Canada] ; Subrahmanyam V. Mantha [Canada] ; Kailash Prasad [Canada]Serum antioxidant enzyme activity in Parkinson's disease
004639 (1992) J. Kalra [Canada] ; A. H. Rajput ; S. V. Mantha ; A. K. Chaudhary ; KAILASH PRASADOxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease
004846 (1990) R F Peppard [Canada] ; C S Lu ; N S Chu ; P. Teal ; W R Martin ; D B CalneParkinsonism with neuroacanthocytosis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (blood)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (blood)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (blood)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022